Exam
Immunity
search
Immunity
, Immune System, Immune Status, Immunology, Innate Immunity, Adaptive Immunity
See Also
Humoral Immunity
(
Immunoglobulin
)
T-Lymphocyte
B-Lymphocyte
Antigen Processing
Complement Pathway
Immunodeficiency
Definitions
Immune System
Defense mechanism against both errant native cells and foreign organism or substance invasion
Distinguishes self from non-self
Eliminates foreign organisms and substances
Responses include humoral immune response and the cell-mediated response
Organs (
Thymus
,
Spleen
,
Tonsil
s,
Lymphatic System
, hematopoetic system)
Cells (
Lymphocyte
s,
Granulocyte
s,
Monocyte
s,
Macrophage
s)
Mole
cules (antibodies, complement,
Cytokine
s)
Innate Immunity (Natural Immunity)
Gene
ralized, immediate immune response not reliant on prior exposure
Predates the evolution of the more specific Immunity provided by antibodies and
Lymphocyte
s
Adaptive Immunity
Organism specific Immunity that relies on prior "memory" of exposure
Immune System evolved beyond the more primitive Innate Immunity
Humoral Immunity
(
Antibody
and
B Cell
response)
Cell mediated Immunity (T Cell Response)
Phagocyte
(and
Phagosome
,
Phagocytosis
)
Immune cells (
Neutrophil
s and
Monocyte
s/
Macrophage
s) are
White Blood Cell
s that engulf pathogens and foreign material
Phagosome
s are the membrane engulfed pathogens
Often combined with lysis by
Lysozyme
s
Lysosome
(and
Lysozyme
)
Lysozyme
-containing vacuoles produced in cellular golgi apparatus
Lysomsomes fuse with
Phagosome
s, resulting in pathogen lysis (esp.
Bacteria
l cell walls)
Lysosome
s, like
Phagosome
s, are found in
Phagocyte
s (
Macrophage
s and
Neutrophil
s)
Opsonin
(and
Opsonization
)
Protein
s (e.g.
Antibody
, complement,
C-Reactive Protein
) that bind a pathogen surface, targeting it for
Phagocytosis
Types
Innate Immunity (Natural Immunity)
Physical Barriers
Skin
Mucosa (e.g. respiratory and
Gastrointestinal Tract
)
Cilia (e.g. respiratory)
Inflammatory Response
C-Reactive Protein
Increases with inflammation and tissue injury
Binds
Bacteria
l surface and facilitates
Phagocytosis
(by
Macrophage
s and
Neutrophil
s)
Prostaglandin
s and
Leukotriene
s
Fatty Acid
s released from injured cells, as well as
Mast Cell
s
Promote inflammation (e.g. vascular permeability,
Neutrophil
chemotaxis, stimulate
Nociceptor
s)
Kinin peptides (kallidin and bradykinin)
Short-lived inflammatory
Protein
s that increase vascular permeability and result in arteriolar dilitation
Cytokine
s
Cytokine
types include
Interleukin
,
Interferon
,
Tumor Necrosis Factor
,
Colony-Stimulating Factor
, TGF-beta
Glycoprotein
s act in inflammatory and immune response via cell to cell communication
Released from cells in response to a trigger (e.g.
Antigen
binding) and bind and activate
Target Cell
s
Secretion Contents
Lysozyme
(e.g. in tears,
Saliva
and in
Neutrophil
s)
Enzymatically degrades cell walls
Acid destroys acid-labile organisms
Sweat
Lactic Acid
Stomach
Gastric Acid (Hydrochloric Acid)
Phagosome
s (
Phagocytosis
)
Phagocyte
s such as
Neutrophil
s (PMNs) and
Macrophage
s attract and engulf organisms (
Phagocytosis
)
Phagocyte
s attract organisms which in turn activate
Phagocytosis
Phagosome
s are later lysed via
Lysosome
s (as below)
Lysosome
s
Neutrophil
's and
Macrophage
's (
Phagocyte
s) golgi apparatus produce
Lysosome
s (vacuoles) that contain
Lysozyme
Lysosome
s fuse with
Phagosome
s to produce phagolysosomes, degrading the engulfed organisms
Lysosome
s may also release their contents extracellularly to lyse larger targets too large to engulf
Spleen
responds to blood borne pathogens
Red Pulp
Vascular Sinusoids at the end of arterioles
Filter blood of
Red Blood Cell
s and non-immunogenic foreign material
White Pulp
Collections of
Macrophage
s, plasma cells, dentritic cells and
Lymphocyte
s
Natural Killer Cell
s (
NK cell
s)
Lymphocyte
s providing protection against
Intracellular Bacteria
and viruses
NK cell
s bind
Major Histocompatibility Complex
1 (
MHC-1
)
MHC-1
is present on normal cells and it inactivates
NK cell
s
MHC-1
is NOT expressed by infected cells
NK activating receptor
Ligand
is expressed
NK cell
s bind infected cells and destroy them
NK cell
mechanisms of infected cell destruction
Cytoplasmic granules
Perforin
Gene
rates pores on cells targeted for destruction
Granzyme
Induces programmed cell death (apoptosis) on entry into
Target Cell
s
Cytokine
s
Interferon
-Gamma (IFN-g)
Activates
Macrophage
s for
Phagocytosis
Image: NKC Mediated Destruction of Infected Host Cells
Complement Pathway
Images
Activation
Classical Pathway (C1, C2, C3, C4)
C1 binds
Antigen
-
Antibody
complex
Alternate Pathway (Properdin, Factor B, Factor D, C3)
Activation via
Microbe
cell surface
Lectin Pathway (Mannose Binding Lectin or MBL)
Mannose Binding Lectin (MBL) binds mannose on
Microbe
surface
Mannose Binding Lectin Associated Proteases (MASP-1, MASP-2) are activated
Classical Pathway (above) is stimulated
Enzyme C3 Convertase (C3bBb or C4b2a) Formation
Enzyme C3 Convertase splits C3 into C3a and C3b
C3a stimulates inflammation (attracts
Neutrophil
s,
Histamine
release)
C3b stimulates
Phagocytosis
, inflammation (as with C3) and lysis (see below)
Opsonization
Microbe
coated with an
Opsonin
, an
Antibody
or complement (e.g. C3b)
Surf
ace
Opsonin
s target
Microbe
s for
Phagocytosis
Phagocytosis
Phagocyte
s such as
Neutrophil
s (PMNs) and
Macrophage
s attract and engulf targeted organisms
Inflammation (via C3a, C5a)
Chemoattraction of
Neutrophil
s
Anaphylatoxic activation of
Mast Cell
s and
Basophil
s to degranulate, releasing
Histamine
s and vasoactives
Inflammation occurs when
Histamine
-induced capillary dilation results in fluid and
Protein
release
Lysis
C3b splits C5 into C5a and C5b
Membrane attack complex or MAC (C5b, C6, C7, C8, C9) binds
Microbe
surface
MAC promotes
Microbe
lysis by creating holes in
Microbe
surface, resulting in leak
Types
Adaptive Immunity
Humoral Immunity
(B-Cells and Antibodies)
Humoral Immunity
(i.e. antibodies) targets extracellular pathogens
B Cell
s
Derivation
Fetal
Liver
Bone Marrow
Pluripotent Stem Cells
Peripheral Migration to Secondary
Lymphoid Tissue
Spleen
Lymph Node
s
Peyer's
Patch
es (
Small Bowel
)
Activation
Images
Recognition
Antigen
binds
B-Lymphocyte Surface Receptor
(BCR)
BCR binding activates
B-Lymphocyte
T-Cell
Independent
Antigen
(e.g. inert
Antigen
s) alone activate B-Cells
T-Cell
Dependent
Antigen
(e.g.
Microbe
s) require added stmulus (e.g. T Cells)
B-Cell Proliferation
Activated
Lymphocyte
s proliferate
B-Cell Differentiation
Plasma Cells (
Antibody
producing cells)
Survive for days to weeks producing antibodies, and without replicating
Memory Cells
Remain in
B-Lymphocyte
pool ready to respond to the same
Antigen
in future
Future
Antigen
response is known as secondary immune response
Antibodies
Images
Immunoglobulin
(Ig)
Immunoglobulin
s (or antibodies) are Y-Shaped
Glycoprotein
s generated by Plasma Cells
Immunoglobulin
stem (Fc) is composed of 2 identical heavy chains
Two
Immunoglobulin A
rms emanate from the stem
Each arm is composed of 2 heavy chains and 2 light chains
The end of each arm contains an
Antigen
binding site (Fab)
Immunoglobulin
s have 2 forms
Membrane bound
Immunoglobulin
s (on surface of B-Cell)
Secretory
Immunoglobulin
(unbound, free-floating)
Monomeric antibodies exist as single
Antibody
molecules (IgE or IgG)
Multimeric antibodies exist as multiple joined antibodies (IgA or IgM)
Connected with J Chains
Immunoglobulin G
(IgG and subclasses IgG1-4)
Monomer accounting for 75% of all
Antibody
, and has a serum
Half-Life
of 23 days
Responsible for long lasting Immunity (secondary immune response) and
Type 2 Hypersensitivity
Immunoglobulin A
(IgA and subclasses IgA1, IgA2)
Dimer (2
Antibody
molecules) when secretory Ig and accounts for 10-15% of all
Antibody
Serum half life of 6 days
Present in body secretions (e.g. tears,
Saliva
, milk) and responsible for mucosal Immunity
Immunoglobulin M
(IgM)
Pentam
er (5
Antibody
molecules) when secretory Ig
Responsible for early, primary
Antibody
response
Immunoglobulin E
(IgE)
Long stem (Fc) monomeric
Antibody
with serum
Half-Life
of only 2.5 days
Reacts to allergans (
Type 1 Hypersensitivity
) and
Parasitic Infection
s
Immunoglobulin
D (IgD)
Monomer with serum half life of 3 days
Membrane bound surface
Antibody
Cell-Mediated Immunity (
T-Cell
s)
Cellular Immunity (i.e. T Cells) target
Intracellular Pathogen
s (e.g. viruses and
Intracellular Bacteria
)
T-Cell
s
Derived in
Bone Marrow
Migrate to
Thymus
Maturation and Differentiation into two cell lines with different
T-Cell
Receptors (CD4 and CD8)
Release into peripheral circulation
T-Cell Surface Receptor
s
T-Cell
Receptors (TCR)
Bind the
Antigen
on the
Antigen Presenting Cell
TCR Types
TCR-alpha-beta (TCRab+)
TCR gamma-delta (TCRgd+)
T-Cell
Co-Receptors
CD4 binds
MHC Class 2
- peptide/
Antigen
complex on surface of
Antigen Presenting Cell
s (APC)
Only
Dendritic Cell
s,
Macrophage
s, B-Cells (
B-Lymphocyte
) present
MHC Class 2
CD8 binds
MHC Class 1
- peptide/
Antigen
complex on surface of
Antigen Presenting Cell
s (APC)
Any nucleated cell can present
MHC Class 1
T-Cell
Types
Effector Cells
T-Helper Cell
s (CD4+ Cells)
Releases
Interferon
Stimulates
Phagocytosis
by
Macrophage
s
Activates
Natural Killer Cell
s
Suppresses viral replication
Releases interleuken 2
Promotes
T-Cell
proliferation (esp. memory cells)
Promotes B-Cell proliferation (memory cells and plasma cells)
T-Cytotoxic Cell
s (CD8+ Cells)
Target and destroy tumor cells and virus-infected cells
Other Cells
Memory Cells
Apoptosis of some cells not otherwise differentiated
Naive
T-Cell Activation
T-Cell
Receptor (TCR) binds to
MHC-Antigen complex
on
Antigen Presenting Cell
s
T-Cell
Surf
ace CD28 binds to B7
Ligand
on
Antigen Presenting Cell
T-Cell
Surf
ace LFA-1 (
Lymphocyte
Function Associated
Antigen
) binds ICAM1 on
Antigen Presenting Cell
s
Interleukin
-2 (IL2) produced by naive T Cells
Stimulate T Cell proliferation
Pathophysiology
Inadequate Host Immune Response
Infections
See
Bacterial Infection
and
Sepsis
See
Viral Infection
See
Parasitic Infection
See
Cutaneous Fungal Infection
,
Fungal Lung Infection
,
Candida Vulvovaginitis
and
Oral Candidiasis
See
Prion Disease
Microorganism
s adapt to host immune response
Microorganism
s may vary their
Antigen
s or only trigger a weak
Antigen
immune response
Bacteria
l encapsulation prevents
Phagocytosis
by
Macrophage
s
Bacteria
l cell wall may be resistant to immune-mediated lysis
Bacteria
may release toxins to counter or degrade host defenses
Endotoxins (esp.
Gram Negative Bacteria
)
Exotoxins (may damage
Macrophage
s)
Aggressins (increase
Bacteria
l virulence, penetration, spread and persistence)
Immunodeficiency
Primary Immunodeficiency
Rare immune disorders of childhood
Gene
tic abnormalities affecting
T-Cell
s, B-Cells,
Phagocyte
s or Complement
Humoral Immunodeficiency
(
B-Cell Disorder
,
Immunoglobulin Disorder
,
Antibody Disorder
)
Cell-Mediated Immunodeficiency
(
T-Cell Disorder
, e.g. DeGeorge Syndrome)
Phagocytic Immunodeficiency
Complement Disorder
s
Secondary
Immunodeficiency
(Acquired
Immunodeficiency
)
Asplenism
(e.g. splenectomy,
Sickle Cell Anemia
)
Immunosuppressant
s
Malnutrition
Cancer involving
Bone Marrow
Radiation Therapy
HIV Infection
or
AIDS
(T Helper cell or
CD4+ Cell
infection)
Pathophysiology
Exaggerated Host Immune Response
Non-
Hypersensitivity Reaction
s
Schwartzman Reaction
Excess
Tumor Necrosis Factor
induced by
Bacteria
l endotoxins resulting in shock state, DIC
Excess
Complement Activation
(confirmed or proposed as mechanism in wide variety of conditions)
Resistant infectious disease
Hereditary Angioneurotic
Edema
Paroxysmal Nocturnal
Hematuria
Alzheimer's Disease
Schizophrenia
Atypical
Hemolytic-Uremic Syndrome
Macular Degeneration
Crohn's Disease
Tichaczek-Goska (2012) Adv Clin Exp Med 21(1):105-14 +PMID: 23214307 [PubMed]
Cytokine Release Syndrome
Sepsis
-like systemic inflammatory reaction due to excessive systemic release of
Cytokine
s by activated
T-Cell
s
Infections
Corona Virus 19
Bubonic Plague
Pandemic
Influenza
1918
Toxic Shock Syndrome
Acute
Graft Versus Host Disease
Allogeneic Graft
with
Hematopoietic Stem Cell Transplant
Chemotherapy
Muromonab-CD3 (OKT3) Infusion
Chimeric Antigen Receptor T Cell Therapy
(
CAR T-Cell Therapy
)
Other Conditions with Exaggerated Host Response
Acute Respiratory Distress Syndrome
(
ARDS
)
Tumor Lysis Syndrome
Hemophagocytic Lymphohistiocytosis
(HLH)
Macrophage
activation syndrome (MAS)
Hypersensitivity Reaction
(
Gell and Coombs Classification
, including autoimmune reactions)
Type 1 -
Immediate Hypersensitivity Reaction
(IgE
Antibody
mediated)
Immediate allergan immune response after repeated exposure (esp. in
Atopic Patient
s)
Examples
Anaphylaxis
(e.g.
Penicillin
)
Urticaria
Angioedema
Anaphylactoid Reaction (e.g.
Anaphylactoid Reaction to Radiocontrast
)
Atopic Allergy
(e.g.
Allergic Rhinitis
,
Allergic Asthma
)
Food Allergy
Bee sting
Allergy
Allergic Occupational Asthma
Type 2 -
Cytotoxic Antibody Reaction
(non-IgE
Antibody
Mediated Reaction)
See
Autoimmunity
Mediated by IgG and IgM (on cell surface or extracellular complex) to specific
Antigen
s
Antibody
-
Antigen
Complex destruction (
Phagocytosis
,
Antibody
cellular cytotoxicity or complement)
Examples
Transfusion Reaction
(
ABO Incompatibility
)
Rhesus Incompatibility (Rh Incompatibility,
Autoimmune Hemolytic Anemia
)
Autoimmune Thrombocytic
Purpura
Hashimoto's Thyroiditis
Grave's Disease
Goodpasture's Syndrome
Delayed transplant
Graft Rejection
Myasthenia Gravis
Mycoplasma pneumoniae
related cold
Agglutinin
s
Polyclonal Activation (triggered by
Microorganism
response, e.g.
Trypanosoma cruzi
)
Montes (2007) J Leukoc Biol 82(5):1027-32 +PMID: 17615380 [PubMed]
Type 3 -
Immune Complex Reaction
Antigen
-
Antibody
immune complexes deposit in tissue (small complexes missed by
Phagocytosis
)
Site of immune complex deposition determines effects (e.g.
Vasculitis
, nephritis,
Arthritis
)
Examples
Serum Sickness
(prototypical
Immune Complex Reaction
)
Systemic Lupus Erythematosus
Erythema Nodosum
Polyarteritis Nodosa
Arthus Reaction (e.g. Farmer's
Lung
)
Rheumatoid Arthritis
Elephantiasis (Wuchereria bancrofti reaction)
Jarisch-Herxheimer Reaction
Type 4 -
Delayed-Type Hypersensitivity
(Cell-Mediated)
Reaction within 2-7 days after exposure
Mediated by Effector T
Lymphocyte
s (CD4+ and CD8+), activated in response to specific
Antigen
s
Examples
Allergic Contact Dermatitis
(e.g. Nickel allergy)
Mantoux
Test (PPD)
Immune
Allergic Contact Dermatitis
after prior
Mycobacterium tuberculosis
exposure
Prevention
See
Vaccine
See
Postexposure Prophylaxis
See
Personal Protection Equipment
Resources
Immune System (Wikipedia)
https://en.wikipedia.org/wiki/Immune_system
References
Goldberg (2014) Physiology, MedMaster, Miami, FL
Mahmoudi (2014) Immunology Made Ridiculously Simple, MedMaster, Miami, FL
Guyton and Hall (2006) Medical Physiology, p. 419-50
Type your search phrase here